New inhaler combo shows promise for COPD patients in Real-World study
NCT ID NCT05535972
First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 21 times
Summary
This study looked at how well the Trelegy Ellipta inhaler works for people with chronic obstructive pulmonary disease (COPD) in real-world settings. Over 12 weeks, 463 adults with COPD used the inhaler, which combines three medicines to help breathing. Researchers measured changes in health status, shortness of breath, and lung function to see if the treatment improved daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Dongguan, 523326, China
Conditions
Explore the condition pages connected to this study.